ATE274914T1 - Verfahren zur herstellung einer zusammensetzung enthaltend modifizierten tierlichen lungensurfactant - Google Patents

Verfahren zur herstellung einer zusammensetzung enthaltend modifizierten tierlichen lungensurfactant

Info

Publication number
ATE274914T1
ATE274914T1 AT96920616T AT96920616T ATE274914T1 AT E274914 T1 ATE274914 T1 AT E274914T1 AT 96920616 T AT96920616 T AT 96920616T AT 96920616 T AT96920616 T AT 96920616T AT E274914 T1 ATE274914 T1 AT E274914T1
Authority
AT
Austria
Prior art keywords
surfactant
lung surfactant
lung
phospholipid
protein
Prior art date
Application number
AT96920616T
Other languages
English (en)
Inventor
Edmund A Egan
Bruce A Holm
William H Ferguson
Original Assignee
Ony Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ony Inc filed Critical Ony Inc
Application granted granted Critical
Publication of ATE274914T1 publication Critical patent/ATE274914T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
AT96920616T 1995-06-07 1996-06-05 Verfahren zur herstellung einer zusammensetzung enthaltend modifizierten tierlichen lungensurfactant ATE274914T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/475,539 US6129934A (en) 1995-06-07 1995-06-07 Modification of animal lung surfactant for treating respiratory disease due to lung surfactant deficiency or dysfunction
PCT/US1996/008828 WO1996040177A1 (en) 1995-06-07 1996-06-05 Modified animal lung surfactant and its therapeutic use

Publications (1)

Publication Number Publication Date
ATE274914T1 true ATE274914T1 (de) 2004-09-15

Family

ID=23888024

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96920616T ATE274914T1 (de) 1995-06-07 1996-06-05 Verfahren zur herstellung einer zusammensetzung enthaltend modifizierten tierlichen lungensurfactant

Country Status (7)

Country Link
US (1) US6129934A (de)
EP (1) EP0831862B1 (de)
AT (1) ATE274914T1 (de)
AU (1) AU5886896A (de)
CA (1) CA2221625A1 (de)
DE (1) DE69633279D1 (de)
WO (1) WO1996040177A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5958902A (en) * 1997-04-16 1999-09-28 Wisconsin Alumni Research Foundation Method and composition for treating sleep apnea
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
BR9912573A (pt) * 1998-07-30 2001-05-02 Colgate Palmolive Co Microemulsão de água em óleo contendo perfume, e, processos para introduzir um perfume em uma composição base de amaciante de tecido livre de perfume e para conferir maciez aos tecidos concomitante com uma fragrância de perfume.
WO2001019392A1 (en) * 1999-09-16 2001-03-22 Byk Gulden Lomberg Chemische Fabrik Gmbh Combination of c1-inh and lung surfactant for the treatment of respiratory disorders
US6156294A (en) 1999-11-28 2000-12-05 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
US6676930B2 (en) 1999-11-28 2004-01-13 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
EP1276495B1 (de) * 2000-04-12 2006-04-19 ALTANA Pharma AG Verwendung von rekombinantem lungensurfactant zur frühbehandlung von akuten lungenerkrankungen
US20040254112A1 (en) * 2000-04-12 2004-12-16 Dietrich Hafner Use of pulmonary surfactant for the early treatment of acute pulmonary diseases
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
PT1280520E (pt) 2000-05-10 2014-12-16 Novartis Ag Pós à base de fosfolípidos para administração de fármacos
US6770619B2 (en) * 2000-09-01 2004-08-03 Marcus Larsson Lung surfactant compositions with dynamic swelling behavior
TWI324518B (en) 2001-12-19 2010-05-11 Nektar Therapeutics Pulmonary delivery of aminoglycosides
US7201901B2 (en) * 2002-05-23 2007-04-10 Ortho-Clinical Diagnostics, Inc. Capture, concentration and quantitation of abnormal prion protein from biological fluids using depth filtration
CA2606688A1 (en) * 2005-05-03 2006-11-09 Ross Allen Ridsdale Phospholipid formulations and uses thereof in lung disease detection and treatment
US20240366682A1 (en) 2021-07-05 2024-11-07 Chiesi Farmaceutici S.P.A. Process for the preparation of a pulmonary surfactant

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55160721A (en) * 1979-06-02 1980-12-13 Tokyo Tanabe Co Ltd Pulmonary surfactant ta-546, its preparation, and remedy for pulmonary hyaline membrane syndrome comprising it as active constituent
JPS5845299A (ja) * 1981-09-10 1983-03-16 東京田辺製薬株式会社 新規な表面活性物質、その製造法及びそれを含有する呼吸窮迫疾候群治療剤
JPS59164724A (ja) * 1983-03-10 1984-09-17 Tokyo Tanabe Co Ltd サ−フアクタント及びそれを含有する呼吸窮迫症候群治療剤
FR2586587B1 (fr) * 1985-08-30 1987-10-23 Adir Nouveaux surfactants artificiels, leur preparation et les compositions pharmaceutiques qui les contiennent.
US5013720A (en) * 1986-05-06 1991-05-07 Abbott Laboratories SAP-6-Val proteins and methods
IT1203873B (it) * 1987-04-08 1989-02-23 Chiesi Farma Spa Composizioni farmaceutiche che lo surfattante polmonare naturale, contengono. metodo di preparazione e
US5164369A (en) * 1988-01-06 1992-11-17 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
DE3921954A1 (de) * 1989-07-04 1991-01-17 Thomae Gmbh Dr K Niedrig-viskose, hochkonzentrierte surfactant-suspension
GB9021080D0 (en) * 1990-09-26 1990-11-07 Univ Western Ontario Lipid extract surfactant and method of producing same

Also Published As

Publication number Publication date
DE69633279D1 (de) 2004-10-07
AU5886896A (en) 1996-12-30
EP0831862B1 (de) 2004-09-01
WO1996040177A1 (en) 1996-12-19
EP0831862A1 (de) 1998-04-01
CA2221625A1 (en) 1996-12-19
US6129934A (en) 2000-10-10

Similar Documents

Publication Publication Date Title
DE69633279D1 (de) Verfahren zur herstellung einer zusammensetzung enthaltend modifizierten tierlichen lungensurfactant
GEP20032976B (en) Artificial Peptides Having Surface Activity and Use Thereof in The Preparation of Artificial Surfactant
CA2285203A1 (en) Compositions containing capsaicin or capsaicin analogues and a local anesthetic
ATE163768T1 (de) Herstellung von prothrombinzeit-reagenzien aus rekombinantem menschlichem gewebefaktor und sythetischen phospholipiden
BR9913722A (pt) Partìculas para fornecimento de um agente ativo aos alvéolos de um paciente humano, e método para a preparação das mesmas, método para fornecimento de um agente ativo aos pulmões de um paciente humano, e método para aumentar a quantidade de um agente ativo inalado depositado no pulmão profundo
DE3886970D1 (de) Natürliches oberflächenwirksames Lungenpräparat, Verfahren zu seiner Herstellung und pharmazeutische Zusammensetzungen.
ATE112684T1 (de) Verwendung von igf-ii zur behandlung von knochenkrankheiten.
DE60043994D1 (de) Stabile wässrige formulierung von interferon, präparationsmethode und dessen verwendung
ES2098207T1 (es) Producto para el cuidado de la piel y procedimiento de utilizacion.
ATE82127T1 (de) N-acetylglucosamin-zubereitungen zur buccalen anwendung.
NO893882D0 (no) Middel til forbedring av lipidmetabolisme og fremgangsmaate ved anvendelse derav.
JP4883906B2 (ja) 再構成サーファクタントの調製用の改善された合成脂質混合物
DE69332654D1 (de) Fragmente eines oberflächenaktiven lungenproteins
ATE183651T1 (de) Verwendung von wachstumsfaktor igf-ii zur beahandlung von gastrointestinalen störungen
ATE333270T1 (de) Pharmazeutische zusammensetzung enthaltend magermilchpulver
UA26313A (uk) Засіб для замісhої терапії захворюваhь дихальhих шляхів, переважhо при сиhдромі задухи
Kobayashi et al. Exogenous porcine surfactant (Curosurf) is inactivated by monoclonal antibody to the surfactant‐associated hydrophobic protein SP‐B
ATE184489T1 (de) Behandlung fehlender milchabsonderung beim menschen
DE69132211D1 (de) Synthetische oberflächenaktive agentien auf der lunge
Calura et al. Ultrastructural Observations on the Wound Healing of Free Gingival Connective Tissue Autografts With and Without Epithelium in Humans.
EP1356814A4 (de) Pharmazeutische emulsionszubereitung
ATE396706T1 (de) Verfahren zur herstellung von liposomalen wirkstoffformulierungen
ES2092969A1 (es) Surfactante pulmonar natural de origen porcino.
RU97102193A (ru) Способ получения стоматологических пластинок из комбинированного трансплантата
DE60025806D1 (de) Verfahren zur herstellung von weinstein und natriumbicarbonat enthaltenden kosmetische zubereitungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties